Feature Your Latest Work

This informal session offers a relaxed environment to connect with peers, exchange ideas, and gain recognition within the viral vector community. With an audience of process development, MSAT, and CMC experts eager to explore new innovations in vector manufacturing, you’ll have the opportunity to present a poster highlighting your latest research, process optimization, or analytical breakthroughs. Don’t miss your chance to share your work and spark valuable collaborations.

  • Demonstrate your thought leadership in viral vector process development and manufacturing
  • Gain visibility for your innovations in upstream, downstream, or analytical optimization
  • Engage in meaningful discussions and receive feedback from industry and regulatory peers
  • Attract the attention of potential collaborators, CDMOs, and solution providers driving the field forward
Viewing poster
poster session socialising
Explaining poster

How to Submit Your Poster

  • You must first register your place to attend the 4th Viral Vector Process Development & Manufacturing Summit
  • Submit an abstract for review to showcase your poster during the Scientific Poster Session
  • You will be notified once your abstract has been accepted along with details of printing and size requirements. We do request an online PDF of the poster 2 weeks prior to the summit
  • Scientific Poster Session: February 26, 2026
  • Abstract Submission Deadline: January 31, 2026

Click the 'Submit Your Poster' button below.

Submit Your Poster

Please note, there is no additional charge, but you must be attending the conference to submit an abstract. Posters should not be used for sales and marketing purposes. All abstracts are subject to approval by the conference organizers, who reserve the right to reject submissions.

If your company offers pay-for services, you will need to submit your poster request to our partnerships team - sponsor@hansonwade.com

 

Explore The Full Event Guide

  • 16+ expert speakers from the likes of Sanofi, Ultragenyx, NCI, USP, Apertura, and Rocket Pharma
  • 2 days of cutting-edge content tackling the toughest challenges in reducing COGs, improving process consistency, and scaling up viral vector production
  • 5 Interactive sessions and 2 hours of dedicated networking
  • Dedicated sessions on upstream and downstream streamlining
  • Global perspectives on regulatory harmonization and pharmacopeial alignment
Download the Agenda
Placeholder Image